VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 64 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,848 | -26.2% | 3,700 | 0.0% | 0.00% | -20.0% |
| Q2 2023 | $5,217 | -11.3% | 3,700 | 0.0% | 0.01% | -37.5% |
| Q1 2023 | $5,883 | +8.9% | 3,700 | 0.0% | 0.01% | +33.3% |
| Q4 2022 | $5,402 | -66.2% | 3,700 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $16,000 | -11.1% | 3,700 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $18,000 | 0.0% | 3,700 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $18,000 | -99.9% | 3,700 | 0.0% | 0.01% | -99.9% |
| Q4 2021 | $13,505,000 | +44916.7% | 3,700 | 0.0% | 5.65% | +40278.6% |
| Q3 2021 | $30,000 | -28.6% | 3,700 | 0.0% | 0.01% | -30.0% |
| Q2 2021 | $42,000 | +23.5% | 3,700 | 0.0% | 0.02% | +53.8% |
| Q1 2021 | $34,000 | – | 3,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 288,571 | $421,314 | 0.28% |
| BVF INC/IL | 3,614,662 | $5,277,407 | 0.22% |
| Samsara BioCapital, LLC | 689,709 | $1,006,975 | 0.22% |
| Rubric Capital Management LP | 1,330,983 | $1,943,235 | 0.08% |
| HAMILTON LANE ADVISORS LLC | 35,791 | $52 | 0.02% |
| MAI Capital Management | 426,916 | $623,297 | 0.01% |
| Jasper Ridge Partners, L.P. | 92,939 | $135,691 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 17,500 | $25,550 | 0.01% |
| RP Management, LLC | 3,700 | $5,402 | 0.01% |
| Laurion Capital Management LP | 698,000 | $1,019,080 | 0.01% |